{"title":"30-55岁表面健康女性动脉粥样硬化指数和脂质比率的评估","authors":"R. M. Gol, M. Rafraf, M. Jafarabadi","doi":"10.5603/AH.A2021.0020","DOIUrl":null,"url":null,"abstract":"Background: Cardiovascular disease (CVD) is the main cause of death worldwide and atherogenic dyslipidemia is an established risk factor for CVD. This cross-sectional study aimed to assess the atherogenic indices and lipid ratios including atherogenic coefficient (AC), atherogenic index of plasma (AIP), cholindex (CI), castelli risk index-1 (CRI-1), CRI-2, and non-HDL-C in women living in the Tabriz, Iran during April – May 2017. \nMaterial and Methods: Anthropometric measurements, fasting serum lipids, and blood pressure of 150 women aged 30-55 years in Tabriz, Iran was evaluated. The atherogenic indices were calculated by the established formulas. \nResults: The prevalence of high AIP, AC, CI, CRI-1, CRI-2 and non-HDL-C ratios were 64.5%, 36.2%, 20.4%, 77%, 7.2% and 44.7%, respectively. In the multiple-adjusted quantile regression analysis, significant relationships were found between CI ratio and diastolic blood pressure (DBP) (B = 3.76, P = 0.035) and between CRI-2 ratio with DBP (B = 0.005, P = 0.042) and age (B = 0.005, P = 0.031). \nConclusions: This study indicated that the majority of studied women had a high risk of CVD based on atherogenic indices. Further public health efforts are required to enhance awareness of women and healthcare providers about preventing and controlling CVD risk.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Assessment of atherogenic indices and lipid ratios in the apparently healthy women aged 30–55 years\",\"authors\":\"R. M. Gol, M. Rafraf, M. Jafarabadi\",\"doi\":\"10.5603/AH.A2021.0020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Cardiovascular disease (CVD) is the main cause of death worldwide and atherogenic dyslipidemia is an established risk factor for CVD. This cross-sectional study aimed to assess the atherogenic indices and lipid ratios including atherogenic coefficient (AC), atherogenic index of plasma (AIP), cholindex (CI), castelli risk index-1 (CRI-1), CRI-2, and non-HDL-C in women living in the Tabriz, Iran during April – May 2017. \\nMaterial and Methods: Anthropometric measurements, fasting serum lipids, and blood pressure of 150 women aged 30-55 years in Tabriz, Iran was evaluated. The atherogenic indices were calculated by the established formulas. \\nResults: The prevalence of high AIP, AC, CI, CRI-1, CRI-2 and non-HDL-C ratios were 64.5%, 36.2%, 20.4%, 77%, 7.2% and 44.7%, respectively. In the multiple-adjusted quantile regression analysis, significant relationships were found between CI ratio and diastolic blood pressure (DBP) (B = 3.76, P = 0.035) and between CRI-2 ratio with DBP (B = 0.005, P = 0.042) and age (B = 0.005, P = 0.031). \\nConclusions: This study indicated that the majority of studied women had a high risk of CVD based on atherogenic indices. Further public health efforts are required to enhance awareness of women and healthcare providers about preventing and controlling CVD risk.\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2021-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/AH.A2021.0020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/AH.A2021.0020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
背景:心血管疾病(CVD)是世界范围内死亡的主要原因,动脉粥样硬化性血脂异常是CVD的一个确定的危险因素。本横断面研究旨在评估2017年4 - 5月居住在伊朗大不里士的妇女的动脉粥样硬化指数和脂质比率,包括动脉粥样硬化系数(AC)、血浆动脉粥样硬化指数(AIP)、胆碱指数(CI)、castelli风险指数-1 (CRI-1)、CRI-2和非hdl - c。材料和方法:对伊朗大不里士150名30-55岁妇女的人体测量、空腹血脂和血压进行评估。用建立的公式计算动脉粥样硬化指数。结果:AIP、AC、CI、CRI-1、CRI-2、非hdl - c高患病率分别为64.5%、36.2%、20.4%、77%、7.2%、44.7%。多重校正分位数回归分析发现,CI比与舒张压(DBP) (B = 3.76, P = 0.035)、CRI-2比与DBP (B = 0.005, P = 0.042)与年龄(B = 0.005, P = 0.031)存在显著相关。结论:这项研究表明,根据动脉粥样硬化指数,大多数被研究的女性患心血管疾病的风险很高。需要进一步的公共卫生努力,以提高妇女和保健提供者对预防和控制心血管疾病风险的认识。
Assessment of atherogenic indices and lipid ratios in the apparently healthy women aged 30–55 years
Background: Cardiovascular disease (CVD) is the main cause of death worldwide and atherogenic dyslipidemia is an established risk factor for CVD. This cross-sectional study aimed to assess the atherogenic indices and lipid ratios including atherogenic coefficient (AC), atherogenic index of plasma (AIP), cholindex (CI), castelli risk index-1 (CRI-1), CRI-2, and non-HDL-C in women living in the Tabriz, Iran during April – May 2017.
Material and Methods: Anthropometric measurements, fasting serum lipids, and blood pressure of 150 women aged 30-55 years in Tabriz, Iran was evaluated. The atherogenic indices were calculated by the established formulas.
Results: The prevalence of high AIP, AC, CI, CRI-1, CRI-2 and non-HDL-C ratios were 64.5%, 36.2%, 20.4%, 77%, 7.2% and 44.7%, respectively. In the multiple-adjusted quantile regression analysis, significant relationships were found between CI ratio and diastolic blood pressure (DBP) (B = 3.76, P = 0.035) and between CRI-2 ratio with DBP (B = 0.005, P = 0.042) and age (B = 0.005, P = 0.031).
Conclusions: This study indicated that the majority of studied women had a high risk of CVD based on atherogenic indices. Further public health efforts are required to enhance awareness of women and healthcare providers about preventing and controlling CVD risk.